Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:paracetamol
gptkb:codeine_phosphate |
| gptkbp:availableOn |
gptkb:Australia
|
| gptkbp:brand |
paracetamol and codeine combination
|
| gptkbp:broadcastOn |
Schedule 4 (Prescription Only Medicine) in Australia
|
| gptkbp:contraindication |
children under 12
severe respiratory disease known hypersensitivity to codeine or paracetamol |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panadeine Forte
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:notRecommendedFor |
pregnancy
breastfeeding |
| gptkbp:overdoseSymptoms |
respiratory depression
liver damage |
| gptkbp:powers |
30 mg codeine phosphate
500 mg paracetamol |
| gptkbp:prescriptionRequired |
true
|
| gptkbp:riskFactor |
addiction
respiratory depression |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation dizziness drowsiness |
| gptkbp:usedFor |
pain relief
|
| gptkbp:bfsParent |
gptkb:Panadeine
|
| gptkbp:bfsLayer |
7
|